Skip to main content

Advertisement

SpringerLink
Log in

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Vermersch P, Kappos L, Gold R, Foley JF, Olsson T, Cadavid D et al (2011) Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 76(20):1697–1704

    Article  PubMed  CAS  Google Scholar 

  2. Clifford DB, De Luca A, DeLuca A, Simpson DM, Arendt G, Giovannoni G et al (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9(4):438–446

    Article  PubMed  CAS  Google Scholar 

  3. Lindå H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T et al (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361(11):1081–1087

    Article  PubMed  Google Scholar 

  4. Vaklavas C, Sotelo-Rafiq EP, Lovy J, Escobar MA, Tsimberidou AM (2010) Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression. Virol J 7:256

    Article  PubMed  Google Scholar 

  5. Kleiter I, Schröder M, Lürding R, Schuierer G, Clifford DB, Bogdahn U et al (2010) Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy. Mult Scler 16(6):749–753

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany

    I. Ayzenberg, N. Trampe, R. Gold & K. Hellwig

  2. Department of Radiology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany

    C. Lukas

Authors
  1. I. Ayzenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Lukas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Trampe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Hellwig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Ayzenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayzenberg, I., Lukas, C., Trampe, N. et al. Value of MRI as a surrogate marker for PML in natalizumab long-term therapy. J Neurol 259, 1732–1733 (2012). https://doi.org/10.1007/s00415-012-6426-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6426-5

Keywords

Search

Navigation